SI-BONE, Inc. (SIBN)
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.
Address
471 EL CAMINO REAL, SUITE 101
SANTA CLARA, CA 95050
Founded
2008
Number of Employees
344
Website
http://www.si-bone.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | $38 | - | - | - | - | - | $38 |
| Average Price | - | - | - | - | - | $4.32 | - | - | - | - | - | $4.32 |
| # Shares Purchased | - | - | - | - | - | 8,830 | - | - | - | - | - | 8,830 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | 247.2% | - | - | - | - | - | 247.2% |
| S&P 500 Return to Date | - | - | - | - | - | 93.1% | - | - | - | - | - | 93.1% |
| Excess Total Return | - | - | - | - | - | 154.1% | - | - | - | - | - | 154.1% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | 92% | - | - | - | - | - | 95% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
People also followed
Never miss an email alert when insiders at SIBN make a trade.
Creating a free account takes less than one minute